SEARCH · Search PubMed
Results for “MYELOFIBROSIS”
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Idiopathic myelofibrosis followed by acute lymphoblastic leukemia.
Explore the source record for details and available documents.
Acute myelofibrosis. Treatment with allogeneic bone marrow transplantation.
Explore the source record for details and available documents.
Idiopathic myelofibrosis with unusually high erythroblastosis in the peripheral blood.
Explore the source record for details and available documents.
Acute megakaryo-monocytic leukemia with acute myelofibrosis.
Explore the source record for details and available documents.
Immune thrombocytopenia in postpolythemic myelofibrosis.
Explore the source record for details and available documents.
Bone marrow failure and myelofibrosis in a case of PVP storage disease.
"PVP storage disease" is a disorder occurring in patients who have received high molecular weight polyvinylpyrrolidone (PVP), which cannot be excreted from the body. These large polymers deposit in the histiocytes and cause proliferation and infiltration of histiocytes in the reticuloendothelial system. There was usually no significant damage to these organs except that prolonged administration might cause bone destruction, skin lesions, arthritis, and polyneuropathy. We describe a patient who had received a large amount of PVP-containing solution for years. Severe bone marrow failure with extensive infiltration of bone marrow by foamy histiocytes occurred later. In addition, she suffered from multiple pathological fractures with spinal cord compression and arthritis of bilateral knee joints.
Hypercalcemia and adrenal insufficiency in a patient with myelofibrosis.
Explore the source record for details and available documents.
Myelofibrosis in golf course groundskeepers.
Explore the source record for details and available documents.
Chronic myelocytic leukemia with features simulating myelofibrosis with myeloid metaplasia.
Explore the source record for details and available documents.
Reticulosarcomatosis in primary myelofibrosis.
Explore the source record for details and available documents.
Metastatic carcinoma simulating agnogenic myeloid metaplasia and myelofibrosis.
Explore the source record for details and available documents.
Chronic myelolytic leukemia versus idiopathic myelofibrosis: a diagnostic problem in bone marrow biopsies.
Explore the source record for details and available documents.
Dermatomyositis and myelodysplastic syndrome with myelofibrosis responding to methotrexate therapy.
Dermatomyositis (DM) has not yet been reported as a complication of myelodysplastic syndrome (MDS). A 50-year-old man was diagnosed as having MDS because of the presence of anemia, the appearance of immature cells in peripheral blood, and the abnormal cellular morphology. A few months later, high fever, myalgia and erythema developed. Although DM symptoms were resistant to high-dose corticosteroid administration, methotrexate (MTX) therapy improved not only the symptoms of DM but also hematologic findings related to MDS. This indicates that immunosuppressive therapy including MTX administration can be useful for patients with MDS with autoimmune symptoms.
Erythroleukemia following erythropoietin therapy, extramedullary hematopoiesis, and splenectomy in a patient with myelofibrosis and myeloid metaplasia.
Explore the source record for details and available documents.
A possible role for STI571 in the treatment of idiopathic myelofibrosis.
Explore the source record for details and available documents.
Second allogeneic transplantation using a reduced-intensity preparative regimen for relapsed myelofibrosis.
Explore the source record for details and available documents.
Idiopathic myelofibrosis associated with dermatomyositis.
Explore the source record for details and available documents.